SHARESIFT
Healthcare · data ~15-min delayed
44.94 EUR -1.01%
| Price | 44.94 EUR |
| Day change | -1.01% |
| Market cap | 44.15B |
| 52-week range | 25.78 – 53.92 |
| P/E (trailing) | — |
| Dividend yield | 0.24% |
| Payout ratio | 163.27% |
| Return on equity | -5.69% |
| Debt / equity | 129% |
| Beta | 0.83 |
| Sector | Healthcare |
| Value score | 48 / 100 |
How the value score is calculated: 13 published tests, weighted to 100.
Bayer Aktiengesellschaft (BAYN.DE) scores 48/100 on this site's value model, a middling reading with some valuation measures favourable and others not. It is classified in Healthcare. The dividend yield is 0.24%, paid from 163% of earnings. Return on equity is -6%, with debt at 129% of equity. On its filings it passes 6 of the nine Piotroski checks, a mixed picture. These are automated readings of reported figures, not a recommendation.
Piotroski F-Score 6 / 9 — nine pass/fail checks on profitability, leverage and efficiency, comparing the latest financial year with the one before.
Updated · prices ~15-min delayed, fundamentals as last reported
Open full interactive analysis →See how it ranks: Germany stocks by value score
Value scoring · Piotroski F-Score · Altman Z · technicals · dividends — free, no sign-up.